Agilent Technologies Receives Expanded FDA Approval for the Use of Dako PD-L1 IHC 22C3 pharmDx Companion Diagnostic in Gastric or Gastroesophageal Junction (GEJ) Cancer

Patients with gastric or GEJ adenocarcinoma whose tumors express PD-L1 can now be identified for potential treatment with KEYTRUDA® (pembrolizumab) using PD-L1 IHC 22C3 pharmDx SANTA CLARA, Calif., September 22, 2017 Agilent Technologies Inc. (NYSE: A) today announced its Dako PD-L1 IHC 22C3 pharmDx assay has an expanded label approved by U.S. Food and Drug... Read more

Shimadzu’s New i-Series Plus Integrated High-Performance Liquid Chromatograph Significantly Improves Analytical Productivity with Automated Pretreatment Operations

Shimadzu Corporation has released the i-Series Plus integrated high-performance liquid chromatograph. With i-Series Plus, pretreatment operations, such as the processes to dilute samples and add reagents, have been automated, resulting in less mistakes and measurement errors and ensuring highly reproducible and reliable data in the analysis of pharmaceuticals and foods. i-Series Plus also has functions... Read more

State Key Laboratory of Biochemical Engineering and PerkinElmer Open Joint Translational Medical Engineering Demonstration Laboratory in Beijing

New Facility Helps Scientists Advance Translational Medical Research WHAT:              PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the opening of the Translational Medical Engineering Demonstration Laboratory at a ceremony on September 19.  Co-founded with the State Key Laboratory of Biochemical Engineering, this facility will serve as a center for... Read more

FBI Approves DNA Detection Kit to Genetically Identify Male Perpetrators of Sexual Assault

FBI Approves DNA Detection Kit to Genetically Identify Male Perpetrators of Sexual Assault Chemistry behind Thermo Fisher Scientific’s Yfiler Plus PCR Amplification Kit helps solve decades-old cold cases SOUTH SAN FRANCISCO, Calif., Sept. 21, 2017 /PRNewswire/ — The United States Federal Bureau of Investigations (FBI) has granted approval for forensic laboratories to upload genetic profiles to... Read more

Shimadzu's New DPiMS-2020 Probe Electrospray Ionization Mass Spectrometer Offers Quick Measurement Without Pretreatment

Shimadzu Corporation has released the DPiMS-2020 probe electrospray ionization mass spectrometer, which can perform mass spectrometry quickly without complicated pretreatment. Usually, a solvent, column, and other materials need to be prepared and an approximate concentration of the sample needs to be checked before performing analysis using a mass spectrometer. There has always been a demand... Read more

MilliporeSigma Introduces Eshmuno® P Anti-A and Anti-B Chromatography Resins for Enhancement of Plasma-Derived Immunoglobulin

Increased safety for patients undergoing immunoglobulin treatment Excellent stability for longer product lifetime Higher quality control with improved product release test Billerica, Massachusetts, September 20, 2017 — MilliporeSigma today launched Eshmuno® P anti-A and Eshmuno® P anti-B affinity chromatography resins specifically designed to remove anti-A and anti-B isoagglutinin antibodies during the manufacturing of plasma-derived immunoglobulin (Ig) therapies.Trace amounts of... Read more

Agilent Technologies Joins with LabCentral to Help Advance Scientific Discovery

Strategic Sponsorship Will Provide Innovative Technology and Nurture Promising Biotechnology Startup SANTA CLARA, Calif., September 19, 2017 Agilent Technologies Inc. (NYSE: A) has announced a platinum sponsorship agreement with LabCentral, a biotech innovation hub based in Cambridge, Massachusetts. LabCentral is an independent, shared laboratory space designed as a launchpad for high-potential life sciences and biotech... Read more

Agilent Announces Expanded Use of Cancer Diagnostic in the United States

Dako PD-L1 IHC 28-8 PharmDx Approved for Two New Indications SANTA CLARA, Calif., September 19, 2017 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved the cancer diagnostic known as PD-L1 IHC 28-8 pharmDx for use in cases of urothelial carcinoma (UC) and of squamous cell carcinoma... Read more